Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Condition:   Gastroesophageal Adenocarcinoma Interventions:   Drug: Paclitaxel;   Drug: Ramucirumab;   Drug: Zanidatamab Sponsors:   Canadian Cancer Trials Group;   Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials